230 related articles for article (PubMed ID: 26280220)
1. Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.
Khan M; Walters LL; Li Q; Thomas DG; Miller JM; Zhang Q; Sciallis AP; Liu Y; Dlouhy BJ; Fort PE; Archer SM; Demirci H; Dou Y; Rao RC
Lab Invest; 2015 Nov; 95(11):1278-90. PubMed ID: 26280220
[TBL] [Abstract][Full Text] [Related]
2. The role of EZH2 as a potential therapeutic target in retinoblastoma.
Zhao Y; Cheng Y; Qu Y
Exp Eye Res; 2023 Feb; 227():109389. PubMed ID: 36669714
[TBL] [Abstract][Full Text] [Related]
3. Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications.
Lee C; Kim JK
J Cell Physiol; 2021 Apr; 236(4):2318-2332. PubMed ID: 32840881
[TBL] [Abstract][Full Text] [Related]
4. Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion.
Guihurt Santiago J; Burgos-Tirado N; Lafontaine DD; Mendoza Sierra JC; Camacho RH; Vecchini Rodríguez CM; Morales-Tirado V; Flores-Otero J
BMC Cancer; 2021 Jan; 21(1):53. PubMed ID: 33430814
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
[TBL] [Abstract][Full Text] [Related]
6. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
[TBL] [Abstract][Full Text] [Related]
7. EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target.
Lin Z; Tang L; Chen S; Zhang W; Lin J; Gao H; Zhang P
Ophthalmic Res; 2023; 66(1):1014-1019. PubMed ID: 37311441
[TBL] [Abstract][Full Text] [Related]
8. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
Lei Q; Shen F; Wu J; Zhang W; Wang J; Zhang L
Oncol Rep; 2014 Jul; 32(1):261-9. PubMed ID: 24807198
[TBL] [Abstract][Full Text] [Related]
9. Compensation by tumor suppressor genes during retinal development in mice and humans.
Donovan SL; Schweers B; Martins R; Johnson D; Dyer MA
BMC Biol; 2006 May; 4():14. PubMed ID: 16672052
[TBL] [Abstract][Full Text] [Related]
10. The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma.
Avedschmidt SE; Stagner AM; Eagle RC; Harocopos GJ; Dou Y; Rao RC
Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6242-6246. PubMed ID: 27842164
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p.
Wu XZ; Cui HP; Lv HJ; Feng L
Biomed Pharmacother; 2019 Apr; 112():108627. PubMed ID: 30797143
[TBL] [Abstract][Full Text] [Related]
12. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors.
Huang X; Yan J; Zhang M; Wang Y; Chen Y; Fu X; Wei R; Zheng XL; Liu Z; Zhang X; Yang H; Hao B; Shen YY; Su Y; Cong X; Huang M; Tan M; Ding J; Geng M
Cell; 2018 Sep; 175(1):186-199.e19. PubMed ID: 30220457
[TBL] [Abstract][Full Text] [Related]
13. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
[TBL] [Abstract][Full Text] [Related]
14. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.
Bohrer LR; Chen S; Hallstrom TC; Huang H
Endocrinology; 2010 Nov; 151(11):5136-45. PubMed ID: 20881251
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
Sun QX; Wang RR; Liu N; Liu C
Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
[TBL] [Abstract][Full Text] [Related]
17. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
18. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6.
Wang J; Wang X; Li Z; Liu H; Teng Y
FEBS J; 2014 Mar; 281(5):1355-1365. PubMed ID: 24289859
[TBL] [Abstract][Full Text] [Related]
20. Targeting HSP90/Survivin using a cell permeable structure based peptido-mimetic shepherdin in retinoblastoma.
Venkatesan N; Kanwar JR; Deepa PR; Navaneethakrishnan S; Joseph C; Krishnakumar S
Chem Biol Interact; 2016 May; 252():141-9. PubMed ID: 27062892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
